National PBM Monograph Template

With a different mechanism of action and side effect profile, sildenafil may be a preferred alternative in many PAH patients, particularly WHO functional class II or III. Drug costs at FDA approved doses are significantly lower than with ERA therapy; however, if higher doses of sildenafil are used, costs may be comparable to that of ERA treatment. ................
................